Member Info for EmeraldCarrots

After yestersays RNS involving preventing babies from going deaf after bad reaction to antibiotics.

https://www.lse.co.uk/rns/GDR/nihr-and-ols-funding-package-aeikgeh1j7jzs7m.html

Perfect for a newspaper article that parents will be very interested in.

All IMHO.

After yestersays RNS involving preventing babies from going deaf after bad reaction to antibiotics.

https://www.lse.co.uk/rns/GDR/nihr-and-ols-funding-package-aeikgeh1j7jzs7m.html

All IMHO.

Roger65.

Looks like you sold your £17.5K shares to early. "Genetic test developed by Manchester researchers to prevent newborn babies going deaf, to be trialled across the UK" is all over the news now........... and no doubt will be picked up in some of the weekend press, so maybe the sp will spike Monday? Stopping babies going deaf will no doubt get a load of attention.

All IMHO.

GoBIGorGoHome.

Your post was ok actually. But It could be made fun of. Appologies.

6p takeover bid.

Then you can stop annoying people here and buy back in 6 months.

All IMHO.

Then it seems to me you will more than double your money. Trouble is a lot of "investors" can't wait a day, let alone months. LOL!

All IMHO, of course!!!

Then it seems to me you will more than double your money. Trouble is a lot of "investors" can't wait a day, let alone months. LOL!

Shagged.

"Yes, spot on indeed. He said it could go up and it could also go down. Quite remarkable really.".

=========================

He could have added it could stay the same, just to absolutely cover all the sceanarios. LOL!

================

I here by predict that AGL shares might go up tomorrow, might go down AND might stay the same. LOL!

About time.

On the cards here after that RNS.

All IMHO.

£500 K to gather the data to get the NHS roll out, and they have confirmed the same data can be used to support the FDA application in the USA! Market cap only £13 million @ 2.4p..............

The future is looking better and better for Genedrive.......

Maybe a re-rating is not as far fetched as some might think.

Any bid woud start a re-rating multiples of the current sp. Everyone knows that.

A bid would need to be 6p a share plus IMHO.

All IMHO.

Much more likely IMHO.

Roger65.

Read the RNS. "Whilst scheduled for a maximum of 18 months, performance data can be submitted to the NICE EVA Evidence Generation team at an earlier point if the team believes the evidence generation requirements have been successfully fulfilled.".

Also the data CAN BE USED TO SUPPORT THE fda application in the USA!!!

Up 8.33%

good news for the FDA applications, both of them.

All IMHO.

Up 8.33%

good news for the FDA application.

DaffyPicker.

"Revenue to Genedrive for the MT-RNR1 ID kit under the programme is expected to be approximately £500,000."

========================

LOL!! That is actually a load of money and a great help. The Data will Help the FDA application too!!!!!

Https://www.lse.co.uk/rns/GDR/nihr-and-ols-funding-package-aeikgeh1j7jzs7m.html

How do we know it's £500,000?

High on the list as far as the market goes. Access to the USA markets will be the making of Genedrive IMHO. As I posted yesterday it has been OVER FOUR MONTHS since the last update, see link below. By the time we get the results it's likely to be about 5 months, or nealy half a year! Some applications are granted in 3 months or even less sometimes. What is going on?????

Last update 15th July!!! >>>

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html